Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICE-II: Adjuvant Chemotherapy in Elderly Breast Cancer
NCT01204437Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Mar 2009
- Primary completion
- Jan 2014
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel and capecitabine in breast cancer (3 arms), sponsored by GBG Forschungs. Primary endpoints: Compliance and Safety and Toxicity. Started Mar 2009; status: completed.
02
Drugs
paclitaxelcapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01204437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204437.